De-escalation not detrimental to patients with bacteremia Antibiotic de-escalation is not detrimental to clinical outcomes in patients with monomicrobial bacteremia due to Enterobacteriaceae, according to study […]
EMA Panel Backs Zanamivir IV for Complicated, Severe Influenza Troy Brown, RN March 01, 2019 The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) […]
Epidemiological update: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo Since the beginning of the outbreak and as of […]
Prevention of cardiac implantable electronic device infection Antibiotic prophylaxis reduces the risk for cardiac implantable electronic device (CIED) infection, but whether administration of antibiotic therapy is […]
NEWS IN INFECTIOUS DISEASES The opioid epidemic and rates of infective endocarditis In the United States, rates of infective endocarditis (IE) associated with injection drug […]
Epidemiological update: West Nile virus transmission season in Europe, 2018 14 Dec 2018 In the 2018 transmission season a higher number of cases were reported compared […]
Algorithmic treatment of staphylococcal bacteremia There is considerable variability in the clinical approach to treatment of staphylococcal bacteremia; standardizing management may be useful to optimize duration […]
Limited role of antibiotics for acute rhinosinusitis Most cases of acute rhinosinusitis are viral in origin. However, antibiotics are frequently prescribed for this condition. A systematic […]
Weekly updates: 2018 West Nile fever transmission season Situation update Between 17 and 23 August 2018, EU Member States reported 136 human cases of West Nile […]
ANTIMICROBIAL AGENTS Short-term doxycycline use in children (June 2018) Tetracycline antibiotics have traditionally been avoided in children <8 years because of permanent tooth discoloration associated with repeated […]